Credit Acceptance Corp. (NASDAQ:CACC) shares increased 1.50% in last trading session and ended the day at $221.28. CACC has a return on assets of 9.90%. Credit Acceptance Corp. (NASDAQ:CACC) quarterly performance is -12.47%.
On 30 September, Credit Acceptance Corporation (NASDAQ:CACC) announced the completion of a $75.0 million revolving secured warehouse facility with an institutional investor. Under this facility, we will contribute loans to a wholly-owned special purpose entity (“SPE”) and the SPE may borrow up to the lesser of 80% of the net book value of the contributed loans or $75.0 million during the facility’s revolving period. The facility will cease to revolve on September 30, 2018.
EMC Corporation (NYSE:EMC) ended the last trading day at $25.96. Company weekly volatility is calculated as 2.40% and price to cash ratio as 6.45. EMC Corporation (NYSE:EMC) showed a weekly performance of 7.45%.
EMC Corporation (NYSE:EMC) has declared a quarterly cash dividend of $0.115 per common share. The dividend will be payable on October 23, 2015 to shareholders of record as of October 1, 2015.
On 07 October, Microvision Inc. (NASDAQ:MVIS) shares moved up 2.93% and was closed at $3.16. MVIS EPS growth in last 5 year was 36.60%. Microvision Inc. (NASDAQ:MVIS) year to date (YTD) performance is 81.61%.
MicroVision, Inc. (NASDAQ:MVIS), announced that its PicoP® display technology is at the heart of the projected display in Sharp’s new RoBoHoN robot with integrated smartphone functionality. This innovative product was launched today at CEATEC Japan 2015.
Qumu Corporation (NASDAQ:QUMU) shares increased 12.50% in last trading session and ended the day at $4.50. QUMU Gross Margin is 44.60% and its has a return on assets of -22.80%. Qumu Corporation (NASDAQ:QUMU) quarterly performance is -40.63%.
Qumu Corporation (NASDAQ:QUMU) announced several new cloud-based features to help enterprises quickly and cost effectively create new video content, as well making it easier than ever for employees to find and consume the most important communications and stay informed.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) caters to the Healthcare space. Its weekly performance is -20.46%. On the last day of trading company shares ended up at $20.14. Aimmune Therapeutics, Inc. (NASDAQ:AIMT) distance from 50-day simple moving average (SMA50) is -12.89%.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT), announced that it has received the European Medicines Agency (EMA) decision endorsing the company’s pediatric investigation plan, or PIP, for AR101 for the treatment of peanut allergy. The decision follows the EMA Paediatric Committee (PDCO) positive opinion on the PIP on August 14, 2015.
Leave a Reply